In terms of laboratory, imaging, and biopsy criteria, 60 (36.6%) and 32 (19.5%) patients exhibited MPO-ANCA (or P-ANCA) positivity (+6) and pulmonary fibrosis or ILD (+3), respectively. This evidence concerns the gene MPO and interstitial lung disease.